| 养心氏片防治慢性缺血性心力衰竭及急性心肌缺血再灌注损伤的实验研究 |
| |
| 引用本文： | 高越,陈安妮,赵亚红,薛丹,安泳潼,柴逸峰,张海. 养心氏片防治慢性缺血性心力衰竭及急性心肌缺血再灌注损伤的实验研究[J]. 药学实践杂志, 2016, 34(5): 403-407,415 |
| |
| 作者姓名： | 高越 陈安妮 赵亚红 薛丹 安泳潼 柴逸峰 张海 |
| |
| 作者单位： | 第二军医大学药学院实验教学中心, 上海 200433,第二军医大学东方肝胆外科医院药材科, 上海 200438,上海医药集团股份有限公司中央研究院, 上海 200123,上海医药集团股份有限公司中央研究院, 上海 200123,上海医药集团股份有限公司中央研究院, 上海 200123,第二军医大学药学院实验教学中心, 上海 200433,第二军医大学东方肝胆外科医院药材科, 上海 200438 |
| |
| 基金项目： | 上海市科委产学研医结合项目（15DZ1900102） |
| |
| 摘 要： | 目的 对养心氏片防治慢性缺血性心力衰竭和急性心肌缺血再灌注损伤作用进行实验研究，为其临床应用提供理论依据。方法 采用冠状动脉结扎法构建慢性缺血性心力衰竭大鼠模型及急性心肌缺血再灌注小鼠心梗模型，随机分为假手术组、模型组、阳性药组、以及养心氏片低、中、高剂量组，通过预给药和造模后给药，检测大鼠超声心电图、ACE、ACD及小鼠心肌梗死面积、CK、LDH、SOD、相关因子，并观察心脏病理学切片的形态学变化。结果 与假手术组相比，模型组的生化指标差异具有统计学意义（P<0.001）；与模型组相比，阳性药组、高剂量养心氏片组生化指标差异具有统计学意义（P<0.001，P<0.01，P<0.05），且能显著减少心肌梗死面积（P<0.01，P<0.05）， 明显改善心肌细胞水肿程度，减少细胞浸润。结论 养心氏片对慢性缺血性心力衰竭、急性心肌缺血再灌注损伤具有明显的预防和治疗作用。
|
| 关 键 词： | 养心氏片 慢性缺血性心力衰竭 急性心肌缺血再灌注 |
| 收稿时间： | 2016-07-20 |
| 修稿时间： | 2016-08-23 |
Experimental study on the effects of Yangxinshi tablets in the prevention and treatment of chronic ischemic heart failure and acute myocardial ischemia reperfusion injury |
| |
| GAO Yue,CHEN Anni,ZHAO Yahong,XUE Dan,AN Yongtong,CHAI Yifeng and ZHANG Hai. Experimental study on the effects of Yangxinshi tablets in the prevention and treatment of chronic ischemic heart failure and acute myocardial ischemia reperfusion injury[J]. The Journal of Pharmaceutical Practice, 2016, 34(5): 403-407,415 |
| |
| Authors: | GAO Yue CHEN Anni ZHAO Yahong XUE Dan AN Yongtong CHAI Yifeng ZHANG Hai |
| |
| Affiliation: | Center of Experimental Teaching, College of Pharmacy, Second Military Medical University, Shanghai 200433, China,Department of Pharmacy, Shanghai Eastern Hepatobiliary Surgery Hospital of Second Military Medical University, Shanghai, 200438, China,Central Research Institute, Shanghai Pharmaceuticals Holding Co.Ltd., Shanghai 200123, China,Central Research Institute, Shanghai Pharmaceuticals Holding Co.Ltd., Shanghai 200123, China,Central Research Institute, Shanghai Pharmaceuticals Holding Co.Ltd., Shanghai 200123, China,Center of Experimental Teaching, College of Pharmacy, Second Military Medical University, Shanghai 200433, China and Department of Pharmacy, Shanghai Eastern Hepatobiliary Surgery Hospital of Second Military Medical University, Shanghai, 200438, China |
| |
| Abstract: | Objective Experimental study on effects of Yangxinshi tablets in the prevention and treatment of chronic ischemic heart failure and acute myocardial ischemia reperfusion injury in order to provide a theoretical basis for its clinical application. Method Rat model of chronic ischemic heart failure and acute ischemia reperfusion mouse model of myocardial infarction were constructed through coronary artery ligation. Those animals were randomized to sham operation group, model group, positive drug group, high Yangxinshi tablet dose group, middle Yangxinshi tablet dose group, low Yangxinshi tablet dose group. Rat electrocardiogram, ultrasound, ACE, ACD, TNF-a, mouse myocardial infarction area, CK, LDH, SOD and related factors were recorded during pre-dosing and post-dosing after modeling. Morphological changes were observed with cardiac pathological section. Results The biochemical indicators in model group were significantly different from sham operation group with statistical significance (P<0.001). Compared to the model group, positive drug group and high Yangxinshi tablet dose group exhibited biochemical differences with statistical significance (P<0.001, P<0.01, P<0.05), significant myocardial infarction area reduction (P<0.01, P<0.05), improvement in myocardial cells and reduction in the cell infiltration. Conclusion Yangxinshi tablets have preventive and therapeutic effects on chronic ischemic heart failure and acute ischemia reperfusion injury. |
| |
| Keywords: | Yangxinshi tablet chronic ischemic heart failure acute myocardial ischemia reperfusion |
|
| 点击此处可从《药学实践杂志》浏览原始摘要信息 |
|
点击此处可从《药学实践杂志》下载全文 |
|
